JESSICA SCHROEDER: Open Payments
NPI 1326502428 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 68 payments from 15 companies in 2025. Trend: 2023 $764 · 2024 $1,065 · 2025 $1,133
Food & beverage: $1,133
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $277 |
| Amgen Inc. | 14 | $185 |
| Lilly USA, LLC | 10 | $147 |
| Novo Nordisk Inc | 7 | $120 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Seqirus USA Inc | 2 | $33 |
Products named: ELIQUIS, OTEZLA, MOUNJARO, PREVNAR 20, JARDIANCE, Wegovy, EVENITY, XIFAXAN.
Industry payments across MI — which companies pay providers there.
